Y, L., S, M., S, A., E, A., D, B., E, B., . . . D, P. (2024). Availability and financing of CAR-T cell therapies: A cross-country comparative analysis. Health policy (Amsterdam, Netherlands), 149, 105153. https://doi.org/10.1016/j.healthpol.2024.105153
Chicago Style (17th ed.) CitationY, Litvinova, et al. "Availability and Financing of CAR-T Cell Therapies: A Cross-country Comparative Analysis." Health Policy (Amsterdam, Netherlands) 149 (2024): 105153. https://doi.org/10.1016/j.healthpol.2024.105153.
MLA (9th ed.) CitationY, Litvinova, et al. "Availability and Financing of CAR-T Cell Therapies: A Cross-country Comparative Analysis." Health Policy (Amsterdam, Netherlands), vol. 149, 2024, p. 105153, https://doi.org/10.1016/j.healthpol.2024.105153.